HSTM Stock Analysis: Buy, Sell, or Hold?
HSTM - HealthStream Inc
$29.06
0.98 (3.49%)
▲
5d:
-0.03%
30d:
+10.41%
90d:
+46.18%
BUY
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 03, 2026
20d
Get Alerted When HSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HSTM shows positive signals but monitor for confirmation. Market pricing in 6.5% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: HSTM shows positive signals but monitor for confirmation. Market pricing in 6.5% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.44
Based on 7.1% avg growth
INTRINSIC VALUE TODAY
$18.90
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSTM is currently trading at $29.06, which is considered extended relative to its 30-day fair value range of $25.52 to $27.99. From a valuation perspective, the stock is trading at a premium (Forward PE: 32.5) compared to its historical average (26.9). At these levels, the market is pricing in 6.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HSTM is in a strong uptrend. Immediate support is located at $25.70, while resistance sits at $30.00. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: HSTM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $32.00 (+14.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSTM is in a strong uptrend. Immediate support is located at $25.70, while resistance sits at $30.00. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: HSTM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $32.00 (+14.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$25.52 -
$27.99
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.3%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading below Wall St target ($32.00)
- NEUTRAL: Trading at premium valuation - market expects 6.5% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$25.52 -
$27.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$25.70
Resistance Level
$30.00
Current Trend
Strong Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
32.46
Wall Street Target
$32.00
(+14.0%)
Revenue Growth (YoY)
10.5%
Earnings Growth (YoY)
42.9%
Profit Margin
6.4%
Valuation Premium vs History
+6.5% premium
PE vs Historical
32.5 vs 26.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.5%
(market-implied from PE analysis)
1-Year Target
$29.91
(+7%)
2-Year Target
$31.85
(+13%)
3-Year Target
$33.92
(+21%)
3-Yr Target (if PE normalizes)
(PE: 32→27)
PE COMPRESSION
$28.11
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 32.5, Growth: 10.2%)
$37.57
(+34%)
Base:
(SPY PE: 21.8, Growth: 10.2%)
$25.21
(-10%)
Bear:
(PE: 18.5, Growth: 10.2%)
$21.43
(-24%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (42x PE), but valuation improves significantly next year (32x PE) as earnings recover.
Trailing PE: 41.82 | Current EPS (TTM): $0.67
Bull Case
$39.79
(+42%)
Analyst growth 29.1%, PE expands to 46.0
Base Case
$36.18
(+29%)
Market implied 29.1%, PE stable at 41.8
Bear Case
$19.05
(-32%)
Severe decline -20.0%, PE contracts to 35.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 12:43 PM ET
Data refreshes hourly during market hours. Next update: 1:43 PM
Data refreshes hourly during market hours. Next update: 1:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 63 BUY |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$34 | 63 BUY |
